JOSIAH WEBER: Open Payments
NPI 1851940779 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 47 payments from 16 companies in 2025. Trend: 2023 $828 · 2024 $1,081 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $226 |
| Novo Nordisk Inc | 9 | $180 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Dexcom, Inc. | 4 | $61 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| PFIZER INC. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Pacira Pharmaceuticals Incorporated | 1 | $35 |
| Corcept Therapeutics | 1 | $32 |
Products named: UBRELVY, XIFAXAN, Rybelsus, AIRSUPRA, QULIPTA, Wegovy, Dexcom G6 Transmitter, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
